We know that 20% of those nonalcoholic fatty liver disease patients will go on to progress to a condition called NASH, which is nonalcoholic Steatohepatitis.

The new study included 55 people with nonalcoholic steatohepatitis and either insulin resistance or type 2 diabetes.

We and others have pointed this out recently for several liver diseases, including chronic viral hepatitis B and c, alcoholic liver disease, and non-alcoholic fatty liver disease.